Both in Pharmaceuticals
Neuphoria Therapeutics vs Mannatech
Over the past year NEUP returned −28.7% and MTEX returned −4.2%; their daily moves had a correlation of 0.15.
NEUP −28.7% MTEX −4.2%Growth of $1, one year, split-adjusted
| Metric | NEUP | MTEX |
|---|---|---|
| Price | $3.36 | $8.52 |
| Market cap | $18.2M | $16.4M |
| Today | −0.89% | +1.67% |
| 1 month | −5.9% | +12.1% |
| 6 months | −35.3% | +91.0% |
| Year to date | −13.4% | +3.3% |
| 1 year | −25.8% | — |
| Revenue growth (YoY) | — | +3.8% |
| Gross margin | — | 76.9% |
| Net margin | — | 3.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | — | $2.5M |
| Dividend yield | — | — |
| Volatility (60d) | 21.4% | 100.6% |
| Short % of float | 0.1% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).